SCHEMBL3601868

SCHEMBL3601868

Cc1ccccc1-c1ccc2ccn(CC(=O)NCCNCC3CCCCC3)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 7/20 0.47
GRIN2B Q13224 4/20 0.47
NTSR1 P30989 2/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
TSHR P16473 3/20 0.41
HSD17B10 Q99714 2/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.40
NPC1 O15118 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3593043 0.89 ALDH1A1 (0.41) BACE1GRIN2BNTSR1KDM4EALDH1A1
SCHEMBL3595148 0.88 KDM4E (0.45) GRIN2BKDM4EALDH1A1HPGDLMNA
SCHEMBL3598451 0.88 ALDH1A1 (0.45) GRIN2BNTSR1KDM4EALDH1A1HPGD
SCHEMBL3604301 0.88 ALDH1A1 (0.40) BACE1GRIN2BNTSR1KDM4EALDH1A1
SCHEMBL3602467 0.87 KDM4E (0.46) GRIN2BKDM4EALDH1A1HPGDLMNA
SCHEMBL3600906 0.86 GRIN2B (0.47) GRIN2BNTSR1KDM4EALDH1A1HPGD
SCHEMBL3604146 0.86 KDM4E (0.45) GRIN2BKDM4EALDH1A1HPGDLMNA
SCHEMBL3591928 0.86 GRIN2B (0.46) GRIN2BKDM4EALDH1A1HPGDLMNA
SCHEMBL3596849 0.85 GRIN2B (0.43) GRIN2BKDM4EALDH1A1HPGDLMNA
SCHEMBL3592867 0.85 GRIN2B (0.50) GRIN2BKDM4EALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 BACE1 3253/4885GRIN2B 2950/4885NTSR1 1072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.